Stabbing Headache as a Sign of Relapses in Multiple Sclerosis

M. Klein,B. Woehrl,G. Zeller,A. Straube

DOI: https://doi.org/10.1111/head.12138

2013-07-01

Abstract:Primary stabbing headache was recently found to be associated in patients with autoimmune disorders such as multiple sclerosis (MS). However, the pathophysiology of such stabbing headaches is largely unknown. Here, we describe a patient with a history of several episodes, each lasting several weeks, with up to 100 paroxysms per day accompanied by an inflammatory cerebrospinal fluid (CSF) syndrome caused by a relapse of MS. In 2010, a 43-year-old Caucasian female was admitted to our hospital because of repeated shortlasting right and left parietal paroxysms. Six years earlier, the patient had had a first similar episode with paroxysms, reaching a frequency of up to 100 per day. A single paroxysm had lasted 1-5 seconds and had been described as stabbing and very intense. Repeated lumbar punctures had revealed a pleocytosis between 18 and 40 cells/mL (normal <5 cells/mL). Abnormalities in cranial magnetic resonance imaging (MRI) were not found, and viral meningitis had been suspected. After treatment with corticosteroids, the stabbing headache had resolved. During the following years, she only suffered from rare attacks of mostly holocephalic headaches with accompanying nausea and photo-/phonophobia, classified as migraine without aura. At admission to our hospital, the patient complained that she had been suffering again from paroxysmal stabbing pain for 6 weeks, located in the right and left parietal regions, occurring up to 100 times per day, similar to the previous episode. No further symptoms were reported; a physical examination did not reveal pathologic findings. Once again, examination of CSF studies showed a mild inflammatory pleocytosis (13 cells/mL) as well as an intrathecal production of oligoclonal immunoglobulin (oligoclonal bands). Microbiological examinations were negative, and no findings indicative of vasculitis were found. A cranial MRI showed some periventricular but also parietal subcortical T2-hyperintense lesions compatible with MS. Similarly to the previous episode, the stabbing headache improved under therapy with cortisone (500 mg methylprednisolone intravenous [i.v.] for 5 days). In the summer 2011, the patient again developed an episode, lasting 4 weeks, of stabbing headaches (approximately 100 per day, located at the right parietal region) and, again, it disappeared under therapy with 500 mg methylprednisolone i.v. for 5 days. At From the Department of Neurology, Ludwig-MaximiliansUniversität München, Klinikum Großhadern, Munich, Germany.